Photo from wikipedia
Eighty per cent of United States advanced cancer patients faces a worsened prognosis due to cancer‐associated cachexia. Inflammation is one driver of muscle atrophy in cachexia, and skeletal muscle‐resident immune… Click to show full abstract
Eighty per cent of United States advanced cancer patients faces a worsened prognosis due to cancer‐associated cachexia. Inflammation is one driver of muscle atrophy in cachexia, and skeletal muscle‐resident immune cells could be a source of inflammation. This study explores the efficacy of cancer activated skeletal muscle‐resident mast cells as a biomarker and mediator of cachexia.
Keywords:
skeletal muscle;
associated cachexia;
muscle;
mast cells;
cancer;
cancer associated
Journal Title: Journal of Cachexia, Sarcopenia and Muscle
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Cachexia, Sarcopenia and Muscle
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!